CAMBRIDGE, Mass., April 26, 2017 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on
Tuesday, May 9, 2017, at 4:30 p.m. ET to review its first quarter 2017
financial results and provide an update on the company.
A live webcast of the conference call can be accessed in the
Investors/Media section of Infinity's website at www.infi.com. To
participate in the conference call, please dial 1-877-316-5293
(domestic) and 1-631-291-4526 (international) five minutes prior to
start time. The conference ID number is 11938616. An archived
version of the webcast will be available on Infinity's website for
30 days.
About Infinity
Infinity is an innovative biopharmaceutical company dedicated to
advancing novel medicines for people with cancer. Infinity is
advancing IPI-549, an oral immuno-oncology development candidate
that selectively inhibits PI3K-gamma. A Phase 1 study in patients
with advanced solid tumors is ongoing. For more information on
Infinity, please refer to Infinity's website at www.infi.com.
Contact:
Jaren Irene Madden, Senior
Director,
Investor Relations and Corporate Communications
Jaren.Madden@infi.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-first-quarter-2017-financial-results-conference-call-and-webcast-300445393.html
SOURCE Infinity Pharmaceuticals, Inc.